AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2012
Dec 21, 2012
30016_dirs_2012-12-21_ae93d88e-675d-4cf5-a176-5680765d5bc0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-12-20
Reporting Person: BROWN WILLIAM E III (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-12-20 | Common Stock | M | 4087 | $29.36 | Acquired | 7259 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-12-20 | Incentive Stock Option (right to buy) | $29.36 | M | 4087 | Disposed | 2015-12-02 | Common Stock (4087) | Direct |
Footnotes
F1: Grant of options to buy shares of common stock becomes exercisable as to 3,405 shares on 12/03/2009, 12/03/2010, 12/03/2011, 12/03/2012, and 12/03/2013.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13